Le Lézard
Classified in: Health
Subject: MISCELLANEOUS

REPEAT: AgraFlora Organics Expands Cannabinoid-Infused Cosmetics/Topicals Distribution to Continental US; Whole Hemp Health Personal Care Line Now Available in 20+ Brick and Mortar Locations Across Canada


VANCOUVER, British Columbia, July 17, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc.  ("AgraFlora" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to provide the following operational guidance and corporate development updates pertaining to its wholly-owned, vertically integrated cannabinoid-infused cosmetics/topicals subsidiary, Canutra Naturals Ltd. ("Canutra"):

By way of its wholly-owned, cannabinoid-infused cosmetics/topicals subsidiary, Canutra, AgraFlora is equipped with robust cultivation, extraction, manufacturing and distribution capabilities from the Company's flagship facility in Kent County, New Brunswick. Canutra owns and operates 76 acres of unzoned, arid agricultural land, including 1,000 feet of river frontage.

The Company's New Brunswick facility, formerly a Federally owned farm and research facility, boasts over 17,500 square feet of commercial-grade production facilities, as well as 12 separate free-standing structures. Canutra was granted an industrial hemp licence by Health Canada for its New Brunswick land parcel and expects the imminent award of its 2019 Health Canada cannabis research license in the coming weeks.

Canutra manufactures and distributes premium personal care, cosmetics and cannabinoid-infused product lines including a suite of trusted consumer brands such as Whole Hemp Health; a Canadian all-natural, hand-made skin care line, formulated with 100% Canadian organic hemp seed oil. Canutra markets its Whole Hemp Health products by way of brick-and-mortar retail outlets, Amazon Prime, as well as direct to consumer, through an integrated Shopify e-commerce platform.

The Company has continued it pre-existing cannabis/hemp research and development partnership with the Universite de Moncton ("UM") and is pursuing ongoing collaborations with UM to augment its IP portfolio.

Leveraging Canutra's turnkey cultivation/manufacturing ecosystem, AgraFlora is positioned to capitalize on current and future market trends in the rapidly expanding cannabinoid-infused consumer package goods ("CPG") space. Existing turnkey cultivation/manufacturing capabilities will expedite the Company's ability to swiftly expand the breadth of its product line to more than 40 SKUs. Canutra is finalizing the development phase of a suite of innovative SKUs including:

Tony Harris, Chief Executive Officer of Canutra stated: "We are thrilled to formally announce the debut of our premium Whole Hemp Health cosmetics line across the continental United States. Compliant distribution south of the border has long been a pinnacle to Canutra's sustainable sales stratagem. Our recent acquisition by AgraFlora, as well as the subsequent expedited nature of the knowledge transfer process, has allowed us to access diverse economies of scale and robust corporate resources, as made evident by our accelerated entry into the U.S. market.  

"By leveraging Covault's tried and tested e-commerce marketing platform, we intend to pursue hyper growth within the enormous addressable U.S. marketplace. Canutra exclusive partnership with Covault's permits us unbridled access to a proprietary marketing toolset, furnished with unique capabilities, extending far beyond what a traditional e-commerce strategy would provide."

Canutra plans to initiate multifaceted social media/e-commerce influencer marketing campaigns, targeting select U.S. marketplaces primed for mass adoption such as New York, Los Angeles and Seattle. The Company will deploy Covault's diverse analytical tool suite to assist with managing and measuring a host of key consumer data analytics.

The Company is also in the process of architecting a network of temporary Canutra/Whole Hemp Health branded pop-up shops, further amplifying AgraFlora's retail footprint and brand presence in an economical and topical manner. Luxury retailers such as Neiman Markus, Nordstrom's and Harrods have signaled corporate initiatives to incorporate premium hemp-based personal skin care into their retail strategies. Canutra plans to pursue supplier relationships to be involved with luxury retailers in the near future.

Hemp Business Journal projects that the global hemp industry will grow to US$1.8 billion in sales by 2020 at 22% 5-year compound annual growth rate ("CAGR"). Personal care products, as well as foodstuffs, including those infused with CBD, are forecasted to lead exponential growth within the global hemp category.  

Brandon Boddy, Chairman and Chief Executive Officer of AgraFlora stated: "Canutra's diverse product offering is situated at the nexus of the US$130-billion global cosmetics/skin care market, and the burgeoning North American cannabinoid market. The North American cannabis industry is forecasted to grow to US$19-billion by 2020 and Canutra is tactically positioned to capture signature market share.

"The combination of pharmaceutical and cosmetics expertise affords Canutra a strategic advantage within the rapidly growing hemp and cannabis topicals industries. The Canutra team has the proven expertise required to design a sales strategy that can be properly executed and is committed to bringing their trusted product portfolio from the farm to the customer's face in a novel and dependable fashion."

About Covault Technologies Inc.

Covault connects brands and their resellers to simplify their co-marketing programs. In the U.S.A. each year, roughly half of the nearly $70 billion of co-op funding that brands offer to their resellers goes unclaimed. Covault is the only platform that streamlines co-marketing empowering resellers to access previously unclaimed funds. Reaching shared consumers through digital and traditional media, brands and their resellers gain market analytics, increase market share and drive sales through the Covault technology.  

About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.

ON BEHALF OF THE BOARD OF DIRECTORS

Brandon Boddy
Chairman & CEO
T: (604) 682-2928 

For additional information:

AgraFlora Organics International Inc.
Tim McNulty
E: [email protected]
T: (800) 783-6056
For French inquiries:
Remy Scalabrini, Maricom Inc.
E: [email protected] 
T: (888) 585-MARI

The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the business plans for AgraFlora Organics described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which are available at www.sedar.com. 


These press releases may also interest you

at 10:02
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....

at 10:00
Minister Responsible for Relations with the First Nations and the Inuit Ian Lafrenière today submitted in the National Assembly the third annual report on the administration of the Act to authorize the communication of personal information to the...

at 10:00
Cobb Outpatient Detox has opened a new facility in Marietta, GA, providing outpatient drug and alcohol detox services. The center aims to assist individuals in overcoming addiction while balancing their work and family commitments. Located near major...

at 10:00
A new report from the Health Care Cost Institute (HCCI) shows that, even with fluctuations in 2020 and 2021, per person health care spending grew from 2018 to 2022. Over the five years, average prices increased by 14% and utilization went up by about...

at 10:00
BioInnovation Institute (BII), an international non-profit foundation, incubating and accelerating world-class life science research, today announces the launch of the BII & Science Translational Medicine Prize for Innovations in Women´s Health and...

at 10:00
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 for multiple advanced solid tumors will be presented...



News published on and distributed by: